{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:22:07Z","timestamp":1788906127703,"version":"build-2803163510"},"reference-count":149,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jacc.2021.05.035","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T17:07:35Z","timestamp":1627319255000},"page":"513-531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Management of Obesity in Cardiovascular\u00a0Practice"],"prefix":"10.1016","volume":"78","author":[{"given":"Jean-Pierre","family":"Despr\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 C.","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Tchernof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Neeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jacc.2021.05.035_bib1","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/eurheartj\/ehm243","article-title":"Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease","volume":"28","author":"Romero-Corral","year":"2007","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.jacc.2021.05.035_bib2","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.05.035_bib3","doi-asserted-by":"crossref","first-page":"17034","DOI":"10.1038\/nrdp.2017.34","article-title":"Obesity","volume":"3","author":"Gonzalez-Muniesa","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.jacc.2021.05.035_bib4","first-page":"13","article-title":"for the GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.05.035_bib6","series-title":"Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018. NCHS Data Brief No. 360","author":"Hales","year":"2020"},{"issue":"21","key":"10.1016\/j.jacc.2021.05.035_bib7","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.jacc.2021.05.035_bib8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004)","volume":"168","author":"Wildman","year":"2008","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.jacc.2021.05.035_bib9","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1172\/JCI129186","article-title":"Metabolically healthy obesity: facts and fantasies","volume":"129","author":"Smith","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"13","key":"10.1016\/j.jacc.2021.05.035_bib10","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/CIRCULATIONAHA.117.029617","article-title":"Cardiovascular and metabolic heterogeneity of obesity: Clinical challenges and implications for management","volume":"137","author":"Neeland","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jacc.2021.05.035_bib11","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/s41366-018-0197-8","article-title":"Duration and stability of metabolically healthy obesity over\u00a030 years","volume":"43","author":"Camhi","year":"2019","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ijo.2017.233","article-title":"Long-term metabolic risk for the metabolically healthy overweight\/obese phenotype","volume":"42","author":"Espinosa De Ycaza","year":"2018","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"10.1016\/j.jacc.2021.05.035_bib13","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1210\/jc.2016-3346","article-title":"Metabolically healthy obesity and ischemic heart disease: a 10-year follow-up of the Inter99 study","volume":"102","author":"Hansen","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/01.ATV.10.4.497","article-title":"Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease","volume":"10","author":"Despr\u00e9s","year":"1990","journal-title":"Arteriosclerosis"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1152\/jappl.1992.72.2.787","article-title":"Quantification of adipose tissue by MRI: relationship with anthropometric variables","volume":"72","author":"Ross","year":"1992","journal-title":"J\u00a0Appl Physiol"},{"issue":"5","key":"10.1016\/j.jacc.2021.05.035_bib16","first-page":"437","article-title":"A\u00a0novel technique for the determination of body fat by computed tomography","volume":"7","author":"Tokunaga","year":"1983","journal-title":"Int J Obes"},{"issue":"7121","key":"10.1016\/j.jacc.2021.05.035_bib17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jacc.2021.05.035_bib18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/ATVBAHA.107.159228","article-title":"Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk","volume":"28","author":"Despr\u00e9s","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.jacc.2021.05.035_bib19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","article-title":"Body fat distribution and risk of cardiovascular disease: an update","volume":"126","author":"Despr\u00e9s","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jacc.2021.05.035_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.jacc.2021.05.035_bib21","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Pich\u00e9","year":"2020","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jacc.2021.05.035_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR Working Group on Visceral Obesity","volume":"16","author":"Ross","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"24","key":"10.1016\/j.jacc.2021.05.035_bib24","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/eurheartj\/ehn387","article-title":"Adipose tissue dysfunction in obesity, diabetes, and vascular diseases","volume":"29","author":"Hajer","year":"2008","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.jacc.2021.05.035_bib25","doi-asserted-by":"crossref","first-page":"E439","DOI":"10.1002\/oby.20135","article-title":"Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults","volume":"21","author":"Neeland","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"10.1016\/j.jacc.2021.05.035_bib26","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.metabol.2009.04.025","article-title":"Age-related differences in inflammatory markers in men: contribution of visceral adiposity","volume":"58","author":"Cartier","year":"2009","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ecl.2020.02.002","article-title":"Visceral fat: culprit or canary?","volume":"49","author":"Jensen","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/nu8030164","article-title":"Altered skeletal muscle fatty acid handling in subjects with impaired glucose tolerance as compared to impaired fasting glucose","volume":"8","author":"Goossens","year":"2016","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.jacc.2021.05.035_bib29","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI21047","article-title":"Splanchnic lipolysis in human obesity","volume":"113","author":"Nielsen","year":"2004","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.jacc.2021.05.035_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010956","article-title":"Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects","volume":"5","author":"Normand-Lauzi\u00e8re","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib31","doi-asserted-by":"crossref","first-page":"E255","DOI":"10.1152\/ajpendo.00416.2010","article-title":"Lipid-induced pancreatic beta-cell dysfunction: focus on in\u00a0vivo studies","volume":"300","author":"Giacca","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib32","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib33","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.28985","article-title":"Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease","volume":"65","author":"Bril","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib34","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/db16-1167","article-title":"Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio Metabolism study","volume":"66","author":"Gastaldelli","year":"2017","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/joim.12641","article-title":"Cardiovascular risk score is linked to subcutaneous adipocyte size and lipid metabolism","volume":"282","author":"Ryden","year":"2017","journal-title":"J\u00a0Intern Med"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/oby.21003","article-title":"Adipose tissue as an immunological organ","volume":"23","author":"Grant","year":"2015","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib37","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrendo.2014.185","article-title":"Biology of upper-body and lower-body adipose tissue\u2014link to whole-body phenotypes","volume":"11","author":"Karpe","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.jacc.2021.05.035_bib40","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ijo.2009.286","article-title":"Gluteofemoral body fat as a determinant of metabolic health","volume":"34","author":"Manolopoulos","year":"2010","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pathol.2018.11.004","article-title":"Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease","volume":"51","author":"Hussain","year":"2019","journal-title":"Pathology"},{"issue":"10","key":"10.1016\/j.jacc.2021.05.035_bib42","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1172\/JCI129190","article-title":"What lipodystrophies teach us about the metabolic syndrome","volume":"129","author":"Mann","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.jacc.2021.05.035_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.3714","article-title":"Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance","volume":"49","author":"Lotta","year":"2017","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.jacc.2021.05.035_bib44","doi-asserted-by":"crossref","first-page":"E1282","DOI":"10.1152\/ajpendo.00220.2003","article-title":"Regional uptake of meal fatty acids in humans","volume":"285","author":"Jensen","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacc.2021.05.035_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2337\/db10-0867","article-title":"Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?","volume":"60","author":"McQuaid","year":"2011","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib46","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ijo.2009.293","article-title":"Rates of lipid fluxes in adipose tissue in\u00a0vivo after a mixed meal in morbid obesity","volume":"34","author":"Mitrou","year":"2010","journal-title":"Int J Obes (Lond)"},{"issue":"11","key":"10.1016\/j.jacc.2021.05.035_bib47","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2337\/db11-1805","article-title":"Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans","volume":"61","author":"Labb\u00e9","year":"2012","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.jacc.2021.05.035_bib48","doi-asserted-by":"crossref","first-page":"E1388","DOI":"10.1152\/ajpendo.00638.2013","article-title":"Improved cardiac function and dietary fatty acid metabolism after modest weight loss in subjects with impaired glucose tolerance","volume":"306","author":"Labb\u00e9","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib49","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2337\/db19-0773","article-title":"Bariatric surgery rapidly decreases cardiac dietary fatty acid partitioning and hepatic insulin resistance through increased intra-abdominal adipose tissue storage and reduced spillover in type 2 diabetes","volume":"69","author":"Carreau","year":"2020","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib50","doi-asserted-by":"crossref","first-page":"E286","DOI":"10.1152\/ajpendo.00474.2019","article-title":"Seven-day overfeeding enhances adipose tissue dietary fatty acid storage and decreases myocardial and skeletal muscle dietary fatty acid partitioning in healthy subjects","volume":"318","author":"Noll","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jacc.2021.05.035_bib51","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/joim.12728","article-title":"Manifestations and mechanisms of myocardial lipotoxicity in obesity","volume":"284","author":"Sletten","year":"2018","journal-title":"J\u00a0Intern Med"},{"issue":"5","key":"10.1016\/j.jacc.2021.05.035_bib52","first-page":"605","article-title":"Abnormal myocardial dietary fatty acid metabolism and diabetic cardiomyopathy","volume":"34","author":"Carpentier","year":"2018","journal-title":"Can J Cardiol"},{"issue":"25 Pt B","key":"10.1016\/j.jacc.2021.05.035_bib53","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"63","author":"Jensen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"31","key":"10.1016\/j.jacc.2021.05.035_bib54","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"issue":"25","key":"10.1016\/j.jacc.2021.05.035_bib55","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. state-level prevalence of adult obesity and severe obesity","volume":"381","author":"Ward","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"10113","key":"10.1016\/j.jacc.2021.05.035_bib56","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults","volume":"390","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jacc.2021.05.035_bib57","first-page":"923","article-title":"Prevalence, profile, and prognosis of severe obesity in contemporary hospitalized heart failure trial populations","volume":"4","author":"Joyce","year":"2016","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib58","first-page":"327","article-title":"The underestimated belly factor: Waist circumference is linked to significant morbidity following isolated coronary artery bypass grafting","volume":"32","author":"Chass\u00e9","year":"2016","journal-title":"Can J Cardiol"},{"issue":"16","key":"10.1016\/j.jacc.2021.05.035_bib59","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2018.3060","article-title":"Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jacc.2021.05.035_bib60","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jama.2020.14590","article-title":"Trends in obesity prevalence by race and Hispanic origin-1999-2000 to 2017-2018","volume":"24","author":"Ogden","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib61","first-page":"153","article-title":"How to choose and use bariatric surgery in 2015","volume":"31","author":"Pich\u00e9","year":"2015","journal-title":"Can J Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2021.05.035_bib62","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/14779072.2017.1352471","article-title":"Effect of bariatric surgery on heart failure","volume":"15","author":"Rodriguez Flores","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"25 Pt B","key":"10.1016\/j.jacc.2021.05.035_bib63","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Goff","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jacc.2021.05.035_bib64","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss","volume":"53","author":"Lavie","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2021.05.035_bib65","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.23242","article-title":"Performance of the Pooled Cohort Equations to estimate atherosclerotic cardiovascular disease risk by body mass index","volume":"3","author":"Khera","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2021.05.035_bib66","doi-asserted-by":"crossref","first-page":"m3324","DOI":"10.1136\/bmj.m3324","article-title":"Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies","volume":"370","author":"Jayedi","year":"2020","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.CIR.102.2.179","article-title":"Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small, dense LDL) in men?","volume":"102","author":"Lemieux","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacc.2021.05.035_bib68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2021.05.035_bib69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2337\/diacare.29.01.06.dc05-1805","article-title":"The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison","volume":"29","author":"Kahn","year":"2006","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib70","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/dc09-1825","article-title":"Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk","volume":"33","author":"Amato","year":"2010","journal-title":"Diabetes Care"},{"issue":"18","key":"10.1016\/j.jacc.2021.05.035_bib71","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJM199610313351804","article-title":"Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects","volume":"335","author":"Perseghin","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib72","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2337\/diacare.26.3.944","article-title":"Does exercise without weight loss improve insulin sensitivity?","volume":"26","author":"Ross","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2021.05.035_bib73","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.med.49.1.235","article-title":"Exercise, glucose transport, and insulin sensitivity","volume":"49","author":"Goodyear","year":"1998","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jacc.2021.05.035_bib74","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1741826710389397","article-title":"Physical activity, metabolic syndrome, and coronary risk: the EPIC-Norfolk prospective population study","volume":"18","author":"Broekhuizen","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jacc.2021.05.035_bib75","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/oby.2011.396","article-title":"Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program","volume":"20","author":"Borel","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.jacc.2021.05.035_bib76","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrendo.2009.78","article-title":"The future of obesity reduction: beyond weight loss","volume":"5","author":"Ross","year":"2009","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib77","first-page":"216","article-title":"Obesity and cardiovascular disease: weight loss is not the only target","volume":"31","author":"Despr\u00e9s","year":"2015","journal-title":"Can J Cardiol"},{"issue":"24","key":"10.1016\/j.jacc.2021.05.035_bib78","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2021.05.035_bib79","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/nu12082212","article-title":"Mediterranean diet and endothelial function: A review of its effects at different vascular bed levels","volume":"12","author":"Torres-Pena","year":"2020","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.jacc.2021.05.035_bib80","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/nu11061386","article-title":"Effects of intermittent energy restriction combined with a Mediterranean diet on reducing visceral adiposity: A randomized active comparator pilot study","volume":"11","author":"Panizza","year":"2019","journal-title":"Nutrients"},{"issue":"14","key":"10.1016\/j.jacc.2021.05.035_bib81","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa2007123","article-title":"Glycemic index, glycemic load, and cardiovascular disease and mortality","volume":"384","author":"Jenkins","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib82","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCULATIONAHA.115.018704","article-title":"Sugar-sweetened beverage consumption is associated with change of visceral adipose tissue over 6 years of follow-up","volume":"133","author":"Ma","year":"2016","journal-title":"Circulation"},{"issue":"10113","key":"10.1016\/j.jacc.2021.05.035_bib83","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/S0140-6736(17)31634-3","article-title":"The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study","volume":"390","author":"Lear","year":"2017","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.jacc.2021.05.035_bib84","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2018.08.2141","article-title":"Promoting physical\u00a0activity and exercise: JACC Health Promotion Series","volume":"72","author":"Fletcher","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib85","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pcad.2014.09.011","article-title":"Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status","volume":"57","author":"Myers","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"issue":"24","key":"10.1016\/j.jacc.2021.05.035_bib86","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1161\/CIR.0000000000000461","article-title":"Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the American Heart Association","volume":"134","author":"Ross","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mayocp.2018.09.019","article-title":"Effect of exercise and pharmacological interventions on visceral adiposity: a systematic review and meta-analysis of long-term randomized controlled trials","volume":"94","author":"Rao","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 3","key":"10.1016\/j.jacc.2021.05.035_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.jacc.2021.05.035_bib89","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc16-0236","article-title":"Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations","volume":"39","author":"Rubino","year":"2016","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib90","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.amjmed.2012.10.010","article-title":"The long-term effectiveness of a lifestyle intervention in severely obese individuals","volume":"126","author":"Unick","year":"2013","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib91","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11695-011-0544-5","article-title":"Does exercise improve weight loss after bariatric surgery? A systematic review","volume":"22","author":"Egberts","year":"2012","journal-title":"Obes Surg"},{"issue":"8","key":"10.1016\/j.jacc.2021.05.035_bib92","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s11695-015-1973-3","article-title":"Is there a role for visceral adiposity in inducing type 2 diabetes remission in severely obese patients following biliopancreatic diversion with duodenal switch surgery?","volume":"26","author":"Auclair","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.jacc.2021.05.035_bib93","first-page":"1627","article-title":"Bariatric surgery in elderly patients: a systematic review","volume":"10","author":"Giordano","year":"2015","journal-title":"Clin Interv Aging"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2021.05.035_bib94","first-page":"S98","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jacc.2021.05.035_bib95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"LaMoia","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jacc.2021.05.035_bib96","doi-asserted-by":"crossref","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib97","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.jacc.2021.05.035_bib98","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"10193","key":"10.1016\/j.jacc.2021.05.035_bib99","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"10157","key":"10.1016\/j.jacc.2021.05.035_bib100","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.jacc.2021.05.035_bib101","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.jacc.2021.05.035_bib102","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"42","key":"10.1016\/j.jacc.2021.05.035_bib103","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1074\/jbc.REV120.008387","article-title":"Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks","volume":"295","author":"Perry","year":"2020","journal-title":"J\u00a0Biol Chem"},{"issue":"22","key":"10.1016\/j.jacc.2021.05.035_bib104","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.jacc.2021.05.035_bib105","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.jacc.2021.05.035_bib106","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","article-title":"Cardiovascular outcomes with ertugliflozin in type 2 diabetes","volume":"383","author":"Cannon","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib107","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.jacc.2021.05.035_bib108","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.jacc.2021.05.035_bib109","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.jacc.2021.05.035_bib110","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.jacc.2021.05.035_bib111","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.jacc.2021.05.035_bib112","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.2337\/dbi18-0008","article-title":"The ascending GLP-1 road from clinical safety to reduction of cardiovascular complications","volume":"67","author":"Drucker","year":"2018","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.jacc.2021.05.035_bib113","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib114","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/jc.2011-2260","article-title":"Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin","volume":"97","author":"Bolinder","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/dom.13520","article-title":"Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease","volume":"21","author":"Shimizu","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.jacc.2021.05.035_bib116","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s40261-019-00785-6","article-title":"Effect of sodium glucose co-transporter 2 inhibitors on liver fat mass and body composition in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus","volume":"39","author":"Arase","year":"2019","journal-title":"Clin Drug Investig"},{"issue":"5","key":"10.1016\/j.jacc.2021.05.035_bib117","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/dc18-1569","article-title":"The SGLT2 inhibitor dapagliflozin reduces liver fat but does not affect tissue insulin sensitivity: A randomized, double-blind, placebo-controlled study with 8-week treatment in type 2 diabetes patients","volume":"42","author":"Latva-Rasku","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jacc.2021.05.035_bib118","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/oby.22798","article-title":"Effects of dapagliflozin on epicardial fat thickness in patients with type 2 diabetes and obesity","volume":"28","author":"Iacobellis","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jacc.2021.05.035_bib119","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13098-017-0275-4","article-title":"Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus","volume":"9","author":"Yagi","year":"2017","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"10.1016\/j.jacc.2021.05.035_bib120","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/oby.22854","article-title":"Effects of empagliflozin treatment on glycerol-derived hepatic gluconeogenesis in adults with obesity: a randomized clinical trial","volume":"28","author":"Neeland","year":"2020","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"10.1016\/j.jacc.2021.05.035_bib121","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2337\/dc17-0589","article-title":"Effects of liraglutide on weight loss, fat distribution, and beta-cell function in obese subjects with prediabetes or early type 2 diabetes","volume":"40","author":"Santilli","year":"2017","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib122","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1507\/endocrj.EJ16-0449","article-title":"Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial","volume":"64","author":"Bouchi","year":"2017","journal-title":"Endocr J"},{"issue":"1","key":"10.1016\/j.jacc.2021.05.035_bib123","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12933-019-0890-5","article-title":"A\u00a0double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients","volume":"18","author":"van Eyk","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib124","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/oby.21718","article-title":"Liraglutide causes large and rapid epicardial fat reduction","volume":"25","author":"Iacobellis","year":"2017","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"10.1016\/j.jacc.2021.05.035_bib125","doi-asserted-by":"crossref","first-page":"bvz042","DOI":"10.1210\/jendso\/bvz042","article-title":"Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity","volume":"4","author":"Iacobellis","year":"2020","journal-title":"J\u00a0Endocr Soc"},{"issue":"9","key":"10.1016\/j.jacc.2021.05.035_bib126","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/dom.12680","article-title":"Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy","volume":"18","author":"Dutour","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.jacc.2021.05.035_bib127","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/hep.30320","article-title":"Liraglutide, sitagliptin, and insulin glargine added to metformin: The effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease","volume":"69","author":"Yan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jacc.2021.05.035_bib128","doi-asserted-by":"crossref","unstructured":"Neeland IJ, Marso SP, Ayers CR, et\u00a0al. Effects of liraglutide on visceral and ectopic fat in adults with overweight\/obesity at high cardiovascular risk: a randomized clinical trial. Paper presented at: American Diabetes Association Scientific Sessions; June 25-29,\u00a02021.","DOI":"10.2337\/db21-221-LB"},{"issue":"1","key":"10.1016\/j.jacc.2021.05.035_bib129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00125-019-05021-6","article-title":"Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation","volume":"63","author":"Bizino","year":"2020","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00125-019-05065-8","article-title":"Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial","volume":"63","author":"McCrimmon","year":"2020","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.jacc.2021.05.035_bib131","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/obr.12433","article-title":"Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis","volume":"17","author":"Zomer","year":"2016","journal-title":"Obes Rev"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib132","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.jacc.2021.05.035_bib133","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa1003114","article-title":"Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects","volume":"363","author":"James","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.jacc.2021.05.035_bib134","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJMoa1808721","article-title":"Cardiovascular safety of lorcaserin in overweight or obese patients","volume":"379","author":"Bohula","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jacc.2021.05.035_bib135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1463-1326.2011.01554.x","article-title":"Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial","volume":"14","author":"Caterson","year":"2012","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"10.1016\/j.jacc.2021.05.035_bib136","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","article-title":"Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl B","key":"10.1016\/j.jacc.2021.05.035_bib137","first-page":"23B","article-title":"Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?","volume":"23","author":"Lemieux","year":"2007","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2021.05.035_bib138","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3945\/ajcn.2008.27268","article-title":"Dietary screening tool identifies nutritional risk in older adults","volume":"90","author":"Bailey","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.jacc.2021.05.035_bib139","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.pcad.2020.09.006","article-title":"Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure","volume":"63","author":"Singh","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"issue":"8","key":"10.1016\/j.jacc.2021.05.035_bib140","first-page":"969","article-title":"Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic function","volume":"29","author":"Martin","year":"2013","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib141","first-page":"172","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction: Detailed phenotypes, prognosis, and response to spironolactone","volume":"8","author":"Cohen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"3","key":"10.1016\/j.jacc.2021.05.035_bib142","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40256-020-00428-8","article-title":"Clinical impact of weight-loss pharmacotherapy in patients with atherosclerotic cardiovascular disease","volume":"21","author":"Pirlet","year":"2021","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2021.05.035_bib143","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.2019.14231","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity","volume":"322","author":"Aminian","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jacc.2021.05.035_bib144","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/obr.12707","article-title":"Effects of intentional weight loss in patients with obesity and heart failure: a systematic review","volume":"19","author":"McDowell","year":"2018","journal-title":"Obes Rev"},{"issue":"2","key":"10.1016\/j.jacc.2021.05.035_bib145","first-page":"159","article-title":"CCS\/CHFS heart failure guidelines: clinical trial update\u00a0on functional mitral regurgitation, SGLT2 inhibitors, ARNI in HFpEF, and tafamidis in amyloidosis","volume":"36","author":"O'Meara","year":"2020","journal-title":"Can J Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2021.05.035_bib146","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/ejhf.1596","article-title":"Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial","volume":"21","author":"Anker","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.jacc.2021.05.035_bib147","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s13300-020-00911-0","article-title":"Dapagliflozin for heart failure with preserved ejection fraction: Will the DELIVER study deliver?","volume":"11","author":"Williams","year":"2020","journal-title":"Diabetes Ther"},{"issue":"5","key":"10.1016\/j.jacc.2021.05.035_bib148","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bluher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1016\/j.jacc.2021.05.035_bib149","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jamapsychiatry.2020.1351","article-title":"Association of symptoms of depression with cardiovascular disease and mortality in low-, middle-, and high-income countries","volume":"77","author":"Rajan","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.jacc.2021.05.035_bib150","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972105244X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972105244X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:45:12Z","timestamp":1760017512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972105244X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":149,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S073510972105244X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.05.035","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Obesity in Cardiovascular\u00a0Practice","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}